Genotype-guided warfarin dosing prevents more adverse outcomes

October 2017, Volume 1673, Issue 1, pp 9–9 | Cite as

Clinical study

First Online: 14 October 2017

This is a preview of subscription content, to check access.

References

1.
Gage BF, et al. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. Journal of the American Medical Association 318: 1115-1124, No. 12, 26 Sep 2017. Available from: URL: http://dx.doi.org/10.1001/jama.2017.11469.CrossRefPubMedGoogle Scholar
2.
Emery JD. Pharmacogenomic Testing and Warfarin: What Evidence Has the GIFT Trial Provided? Journal of the American Medical Association 318: 1110-1112, No. 12, 5 Oct 2017. Available from: URL: http://dx.doi.org/10.1001/jama.2017.11465.CrossRefPubMedGoogle Scholar